NCT02499224 Safety and Pharmacokinetics Study of YYB101 in Advanced Solid Tumors Patients Who Are Refractory to Standard Therapy Status COMPLETED Phase PHASE1
NCT02498912 Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02496949 A Phase Ib Study to Assess Safety and Efficacy of Oral Icaritin in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02478866 Safety and Pharmacokinetics of BPI-9016M in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02476955 Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole Status TERMINATED Phase PHASE1
NCT02457962 Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study Status RECRUITING Phase N/A
NCT02451007 Evaluation of the Effect of Lurbinectedin (PM01183) on Cardiac Repolarization in Patients With Selected Solid Tumors Status COMPLETED Phase PHASE2
NCT02442531 A Study of CriPec® Docetaxel Given to Patients With Solid Tumours Status COMPLETED Phase PHASE1
NCT02439489 Study of the Combination of BKM120 and Cisplatin or Carboplatin in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02435927 ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin Status UNKNOWN Phase PHASE1
NCT02426892 Nivolumab and HPV-16 Vaccination in Patients With HPV-16 Positive Incurable Solid Tumors Status COMPLETED Phase PHASE2
NCT02423057 Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02395068 Pharmacokinetics Study of Nimotuzumab in Patients With Solid Tumors Status UNKNOWN Phase PHASE1
NCT02379416 Combination Nilotinib and Paclitaxel in Adults With Relapsed Solid Tumors Status COMPLETED Phase PHASE1
NCT02368106 Prospective Patient Registry for Radiation Oncology Techniques and Quality Status WITHDRAWN Phase N/A
NCT02354612 Open Label Continuation Study of TRC105 for Patients Who Have Completed a Prior TRC105 Trial Status NO_LONGER_AVAILABLE Phase N/A
NCT02350673 A Study of Intravenous (IV) Cergutuzumab Amunaleukin and Atezolizumab in Combination in Participants With Locally Advanced and/or Metastatic Solid Tumors Status COMPLETED Phase PHASE1